It seemed that nothing could stop Altria (MO) shares. Except for two minor corrections in 2015 and 2016 when concerns that rising interest rates would reduce the stock's attractiveness for income investors, Altria rallied for more than three years.

Shares marked a new all-time high of $77.79 a few months ago, but then suddenly and surprisingly the FDA announced a comprehensive regulatory plan to fight tobacco-related disease and death on July 28. The FDA said it intends to begin a public dialogue about lowering nicotine levels in cigarettes to non-addictive levels which is obviously a threat to Altria.

READ FULL ARTICLE HERE